Coronary slow flow phenomenon: An angiographic curiosity

Indian Heart Journal

Volumn 56, Issue 6, 2004, Pages 613-617

  Singh, Sandeep ^a   Kothari, S S ^a   Bahl, V K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; DILTIAZEM; ENDOTHELIN 2; MIBEFRADIL; NITRIC OXIDE; VERAPAMIL;

ANGIOCARDIOGRAPHY; CONNECTIVE TISSUE DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY REPERFUSION; CORONARY SLOW FLOW PHENOMENON; EDITORIAL; ELECTROCARDIOGRAM; EPICARDIUM; HUMAN; INTRAVASCULAR ULTRASOUND; MYOCARDIAL DISEASE; PATHOPHYSIOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS; VALVULAR HEART DISEASE;

CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HUMANS;

EID: 14144253673     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (42)

1. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven-year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986; 7: 479-483
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries - a new angiographic finding. Am Heart J 1972; 84: 66-71
3. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology 2002; 97: 197-202
4. Kelly RF, Sompalli V, Sattar P, Khankari K. Increased TIMI frame counts in cocaine users: a case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol 2003; 26: 319-322
5. Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe C, Thompson B, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994; 74: 531-537
6. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-381
7. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54
8. Stone GW, Brodie BR, Griffin JJ, Morice MC, Costantini C, St Goar FG, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998; 31: 23-30
9. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88
10. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 2001; 52: 507-514
11. Machado Cesar LA. Coronary slow flow phenomenon: revisiting a concept not so new. Cardiology 2003; 100: 47
12. Demirkol MO, Yaymaci B, Mutlu B. Dipyridamole myocardial perfusion single photon emission computed tomography in patients with slow coronary flow. Coron Artery Dis 2002; 13: 223-229
13. Cesar LA, Ramires JA, Serrano Junior CV, Meneghetti JC, Antonelli RH, da-Luz PL, et al. Slow coronary run-off in patients with angina pectoris: clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res 1996; 29: 605-613
14. Voelker W, Euchner U, Dittmann H, Karsch KR. Long-term clinical course of patients with angina and angiographically normal coronary arteries. Clin Cardiol 1991; 14: 307-311
15. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 2003; 146: 84-90
16. Kapoor A, Goel PK, Gupta S. Slow coronary flow - a cause for angina with ST segment elevation and normal coronary arteries: a case report. Int J Cardiol 1998; 31; 67: 257-261
17. Atak R, Turhan H, Sezgin AT, Yetkin O, Senen K, Ileri M, et al. Effects of slow coronary artery flow on QT interval duration and dispersion. Ann Noninvasive Electrocardiol 2003; 8: 107-111
18. De Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech JW, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation 2001; 104: 2401-2406
19. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-972
20. Clarke JG, Davies GJ, Kerwin R, Hackett D, Larkin S, Dawbarn D, et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1987; 1: 1057-1059
21. Hirata K, Matsuda Y, Akita H, Yokoyama M, Fukuzaki H. Myocardial ischaemia induced by endothelin in the intact rabbit: angiographic analysis. Cardiovasc Res 1990; 24: 879-883
22. 2 levels in coronary sinus in patients with angiographically normal coronary arteries. Cathet Cardiovasc Diagn 1987; 13: 162-166
23. Van Lierde J, Vrolix M, Sionis D, De Geest H, Piessens J. Lack of evidence for small vessel disease in a patient with "slow dye progression" in the coronary arteries. Cathet Cardiovasc Diagn 1991; 23: 117-120
24. Yaymaci B, Dagdelen S, Bozbuga N, Demirkol O, Say B, Guzelmeric F, et al. The response of the myocardial metabolism to atrial pacing in patients with coronary slow flow. Int J Cardiol 2001; 78: 151-156
25. Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14: 155-161
26. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991; 84: 1087-1099
27. Pekdemir H, Cin VG, Cicek D, Camsari A, Akkus N, Doven O, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004; 59: 127-33
28. Kruger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronopathy"). J Am Coll Cardiol 1999; 34: 1461-1470
29. Rim SJ, Leong-Poi H, Lindner JR, Wei K, Fisher NG, Kaul S. Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation 2001; 104: 2704-2709
30. Pickart L. Fat metabolism, the fibrinogen/fibrinolytic system and blood flow: new potentials for the pharmacological treatment of coronary heart disease. Pharmacology 1981; 23: 271-280
31. Kelly RF, Sompalli V, Sattar P, Khankari K. Increased TIMI frame counts in cocaine users: a case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol 2003; 26: 319-322
32. Pekdemir H, Polat G, Cin VG, Camsari A, Cicek D, Akkus MN, et al. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol 2004; 97: 35-41
33. Camsari A, Pekdemir H, Cicek D, Polat G, Akkus MN, Doven O, et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003; 67: 1022-1028
34. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol 2004; 44: 57-62
35. Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol 1990; 258: H515-H520
36. Fam WM, McGregor M. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 1968; 22: 649-659
37. Chilian WM, Layne SM, Klausner EC, Eastham CL, Marcus ML. Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol 1989; 256: H383-H390
38. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001; 87: 777-779
39. Gustafsson F, Andreasen D, Salomonsson M, Jensen BL, Holstein-Rathlou N. Conducted vasoconstriction in rat mesenteric arterioles: role for dihydropyridine-insensitive Ca(2+) channels. Am J Physiol Heart Circ Physiol 2001; 280: H582-H590
40. Perez-Reyes E. Paradoxical role of T-type calcium channels in coronary smooth muscle. Mol Interv 2004; 4: 16-18
41. Welker HA, Wiltshire H, Bullingham R. Clinical pharmacokinetics of mibefradil. Clin Pharmacokinet 1998; 35: 405-423
42. Doddareddy MR, Jung HK, Lee JY, Lee YS, Cho YS, Koh HY, et al. First pharmacophoric hypothesis for T-type calcium channel blockers. Bioorg Med Chem 2004; 12: 1605-1611